UBS AM
REPL icon

UBS AM’s Replimune Group REPL Stock Holding History

UBS AM’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97K Buy
388
+1
+0.3% +$8 ﹤0.01% 3535
2025
Q4 		$3.76K Sell
387
-74,027
-99% -$629K ﹤0.01% 3029
2025
Q3 		$312K Sell
74,414
-51,944
-41% -$332K ﹤0.01% 2199
2025
Q2 		$1.17M Buy
126,358
+39,600
+46% +$346K ﹤0.01% 2351
2025
Q1 		$846K Buy
86,758
+20,996
+32% +$260K ﹤0.01% 2374
2024
Q4 		$796K Sell
65,762
-15,402
-19% -$187K ﹤0.01% 2452
2024
Q3 		$890K Sell
81,164
-6,759
-8% -$68.7K ﹤0.01% 2458
2024
Q2 		$791K Buy
87,923
+73,543
+511% +$513K ﹤0.01% 2479
2024
Q1 		$117K Hold
14,380
– – ﹤0.01% 2490
2023
Q4 		$121K Buy
+14,380
New +$167K ﹤0.01% 2518
2023
Q1 		– Sell
-20,735
Closed -$564K – 2707
2022
Q4 		$564K Buy
20,735
+8,996
+77% +$187K ﹤0.01% 2134
2022
Q3 		$203K Buy
+11,739
New +$224K ﹤0.01% 2605
2022
Q1 		– Sell
-16,764
Closed -$454K – 2815
2021
Q4 		$454K Hold
16,764
– – ﹤0.01% 2594
2021
Q3 		$497K Hold
16,764
– – ﹤0.01% 2503
2021
Q2 		$644K Buy
16,764
+1,184
+8% +$40.5K ﹤0.01% 2434
2021
Q1 		$475K Sell
15,580
-1,120
-7% -$41.9K ﹤0.01% 2410
2020
Q4 		$637K Buy
+16,700
New +$696K ﹤0.01% 2201

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM's REPL Position: Q1 2026 in Review

UBS AM increased its Replimune Group (REPL) stake by 0.26% in Q1 2026, buying an estimated $8 and bringing the position to 388 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3535.

UBS AM first reported a position in REPL in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.17M in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • UBS AM held 388 shares of Replimune Group worth $2.97K as of Q1 2026.
  • UBS AM bought 1 Replimune Group share in Q1 2026, an estimated $8.
  • Replimune Group made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #3535 holding.
  • UBS AM first reported a position in Replimune Group in Q4 2020 and has held it in 17 quarters since.
  • UBS AM's Replimune Group position peaked at $1.17M in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.